Foundation Medicine, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
Roche Acquires Foundation Medicine For $137 Per Share Or $2.4B
Article By: The Fly
Tuesday, June 19, 2018 8:10 AM EDT
Roche and Foundation Medicine announced they have entered into a definitive merger agreement for Roche to acquire the outstanding shares of Foundation Medicine not already owned by Roche and its affiliates at a price of $137.00 per share in cash.
In this article: RHHBY, FMI
Read
Foundation Medicine - Chart Of The Day
Article By: Jim Van Meerten
Wednesday, June 6, 2018 5:29 AM EDT
Revenue expected to grow 49.20% this year and another 40.70% next year.
In this article: FMI Also: TM
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EDT
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read
Biopharmaceuticals Portfolio In A Biotech Bull Market
Article By: Rod Raynovich
Tuesday, September 5, 2017 11:08 PM EDT
Biotech stocks broke through the July sector highs as tracked by major ETFs. However we are still about 25% off the July 2015 bubble highs but supported by good earnings fundamentals, strong technicals and potentially a seasonal strong Q4.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, BIIB, GILD, XBI, ABBV, KITE, BLUE, FMI
Read
Investors Expecting Growth From Large Caps And M&A From Mid-Caps
Article By: Rod Raynovich
Tuesday, August 15, 2017 9:37 PM EDT
Biotech stocks in general have recovered from last week’s sell-off and remain in a monthly trend up despite a topping pattern from July. Despite weak seasonality and lack of M&A the sector is holding lows with good volume.
In this article: BMY, IBB, AMGN, CELG, GILD, XBI, XLV, ABBV, BLUE, FMI
Read

PARTNER HEADLINES

Latest Tweets for $FMI

No tweets yet!